Lexaria Bioscience Corp (NAS:LEXX)
$ 2.99 0.07 (2.4%) Market Cap: 47.25 Mil Enterprise Value: 41.50 Mil PE Ratio: 0 PB Ratio: 5.64 GF Score: 47/100

Lexaria Bioscience Corp at Benzinga Virtual Global Small Cap Conference Transcript

May 13, 2021 / 07:50PM GMT
Release Date Price: $6.5 (+4.33%)
Spencer Israel
Benzinga - Moderator

All right, a little while ago, somebody in chat was pounding the table. They were like where is LEXX? Where is LEXX? Well, LEXX is here. I don't remember who that was. It was like two hours ago, but LEXX is here. Chris Bunka, the CEO and Chairman of Lexaria Bioscience, LEXX. See, there he is, I wasn't lying to you. Chris, how are we doing?

Chris Bunka
Lexaria Bioscience Corp. - Chairman of the Board & CEO

That's a great introduction. I'm doing great. How are you doing today?

Spencer Israel
Benzinga - Moderator

I'm doing great; I'm not as hyped up as whoever that was in our chat. They was like, where is LEXX, and I was like, he's coming? I don't know, it's not time for him yet, but he's here now. So Chris, there we go. Can we get in presentation mode, please?

Chris Bunka
Lexaria Bioscience Corp. - Chairman of the Board & CEO

You know, it's just not working that way. We've been struggling with it the last 30 minutes. So this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot